Cytomab 100mg (Rituximab Vials) 100mg/10ml

Cytomab 100mg is a rituximab biosimilar injection used for immune-related conditions. This 100mg/10ml vial supports targeted therapy with precise dosing. Ideal for clinics and home care under refrigeration. Reliable treatment option for autoimmune and oncology support.

Strength

100mg/10ml

Pack Size

Storage

2-8°

Manufacturer / TM Owner

Alkem Laboratories Ltd

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Cytomab 100mg is used to treat autoimmune disorders like rheumatoid arthritis and certain blood cancers such as non-Hodgkin lymphoma. It targets specific immune cells to reduce inflammation and abnormal cell growth. Patients often ask, what is rituximab used for in these conditions. It may also be prescribed for other immune-mediated diseases when standard treatments are ineffective.

Side Effects

Cytomab 100mg works by binding to CD20 proteins on B-cells, helping regulate the immune system. Common effects include temporary reduction in immune response and white blood cell counts. Some patients report mild flu-like symptoms after administration. These effects typically resolve as the body adjusts to treatment.

Precautions & Warnings

Store Cytomab 100mg vials between 2-8°C and protect from light. Do not freeze or shake vigorously. Always check the vial for particles or discoloration before use. Use within the recommended timeframe after opening. Keep out of reach of children and pets.

Avoid Interactions

Cytomab 100mg may interact with vaccines, blood pressure medications, and immunosuppressants. Avoid live vaccines during treatment due to reduced immune response. Inform your healthcare provider about all medications, including over-the-counter drugs. Alcohol and certain antibiotics may also affect how Cytomab works.

Frequently Asked Questions

Rituximab is primarily used to treat autoimmune diseases like rheumatoid arthritis and certain blood cancers such as non-Hodgkin lymphoma.

Store between 2-8°C and protect from light; do not freeze or shake the vial.

Avoid live vaccines during treatment due to reduced immune response; consult your healthcare provider.

Common effects include flu-like symptoms and temporary changes in white blood cell counts.

Yes, Cytomab 100mg is a rituximab biosimilar injection manufactured by Alkem Laboratories.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.